Insider Purchases: Inside the Buy

Tag: Funanc1al Stocks to Watch

Cartoon of Elevance CEO climbing a jagged mountain made of stock chart lines, holding a $2.4M rope, with clouds of healthcare cost pressure swirling.

Can Elevance Reach Higher Elevations? The CEO Thinks So

📉 After falling nearly 50% from its highs, Elevance Health just got a $2.4M vote of confidence from its CEO. Is this the cure—or just another symptom? 🏥 Dive into the numbers, the risks, and the potential rewards. And yes, there will be icons. 📊💊📈

Read entire article

Tags: CEO insider buying, CEOConfidence, ElevanceHealth, ELV, Funanc1al, Funanc1al Contrarian Plays, Funanc1al Insider Series, Funanc1al Stocks to Watch, Funanc1alEdge, Funanc1alFinance, Funanc1alFun, Funanc1alHumor, Funanc1alInsiderSeries, Funanc1alInvesting, Funanc1alStocks, HealthcareStocks, InsiderBuying, StockMarketHumor, StocksToWatch, ValueInvesting
Cartoon of Avantor directors in lab coats pouring cash into beakers, with a new CEO stirring the mix like a scientist plotting value creation.

Avantor: A New CEO, New Numbers, and Insiders Keep Buying 💊🔬

Avantor (AVTR) just added a seasoned CEO, posted solid cash flow despite flat sales, and insiders keep buying big. Is this lab supplier quietly building shareholder value?

Read entire article

Tags: Avantor Stock, AVTR, Biopharma Supply Chain, Biotech Supply Chain, Biotech Support Industry, CEO Transition, CEO Transition Stocks, Change in Management, Cost Reduction Plan, Debt Reduction, Emmanuel Ligner, Funanc1al for Investors, Funanc1al Humor, Funanc1al Insider Series, Funanc1al Investing, Funanc1al Stocks to Watch, Funanc1al Turnaround Plays, Funanc1alEdge, Insider Buys, Lab Economy, Life Sciences Stocks, Science Stocks, Stock Market Humor, value investing, Value Trap or Comeback, Value Trap or Value Play